Find in Library

Rhino-orbital mucormycosis is a life-threatening opportunistic fungal infection, which affects mainly immunocompromised hosts. It is commonly caused by ubiquitous fungi belonging to the order Mucorales, family Mucoraceae, which is also commonly known as the black fungus among the general population. The prevalence of mucormycosis (approximately 0.14 cases/1000 population) in India is about 80 times higher than in other developed countries. Despite aggressive treatment with surgical debridement and timely antifungal administration, the overall mortality rate is high. COVID 19 pandemic has led to an increase in the incidence of rhino-orbital mucormycosis. A multidisciplinary approach with early diagnosis and timely treatment with good control of glycemic levels, judicious use of steroids, and addressing immune status of patients helps in reducing the mortality and aids in improving survival rates of mucormycosis patients.